574 related articles for article (PubMed ID: 17265504)
1. Immunolocalization of interleukin-1 receptors in the sarcolemma and nuclei of skeletal muscle in patients with idiopathic inflammatory myopathies.
Grundtman C; Salomonsson S; Dorph C; Bruton J; Andersson U; Lundberg IE
Arthritis Rheum; 2007 Feb; 56(2):674-87. PubMed ID: 17265504
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1 expression in inflammatory myopathies: evidence of marked immunoreactivity in sarcoid granulomas and muscle fibres showing ischaemic and regenerative changes.
Authier FJ; Mhiri C; Chazaud B; Christov C; Cherin P; Barlovatz-Meimon G; Gherardi RK
Neuropathol Appl Neurobiol; 1997 Apr; 23(2):132-40. PubMed ID: 9160898
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor is highly expressed in muscle tissue of patients with polymyositis and patients with dermatomyositis.
Grundtman C; Tham E; Ulfgren AK; Lundberg IE
Arthritis Rheum; 2008 Oct; 58(10):3224-38. PubMed ID: 18821695
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1 (IL-1alpha and IL-1beta) and its receptors (IL-1RI, IL-1RII, and IL-1Ra) in prostate carcinoma.
Ricote M; García-Tuñón I; Bethencourt FR; Fraile B; Paniagua R; Royuela M
Cancer; 2004 Apr; 100(7):1388-96. PubMed ID: 15042672
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of interleukin-1alpha, interleukin-1beta, and cell adhesion molecules in muscle tissue following corticosteroid treatment in patients with polymyositis and dermatomyositis.
Lundberg I; Kratz AK; Alexanderson H; Patarroyo M
Arthritis Rheum; 2000 Feb; 43(2):336-48. PubMed ID: 10693873
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of interleukin 1alpha and MHC class I in muscle tissue of patients with chronic, inactive polymyositis and dermatomyositis.
Nyberg P; Wikman AL; Nennesmo I; Lundberg I
J Rheumatol; 2000 Apr; 27(4):940-8. PubMed ID: 10782820
[TBL] [Abstract][Full Text] [Related]
7. Effects of immunosuppressive treatment on interleukin-15 and interleukin-15 receptor α expression in muscle tissue of patients with polymyositis or dermatomyositis.
Zong M; Loell I; Lindroos E; Nader GA; Alexanderson H; Hallengren CS; Borg K; Arnardottir S; McInnes IB; Lundberg IE
Ann Rheum Dis; 2012 Jun; 71(6):1055-63. PubMed ID: 22267334
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of the aberrant expression of the inflammation mediator high mobility group box chromosomal protein 1 in muscle tissue of patients with polymyositis and dermatomyositis treated with corticosteroids.
Ulfgren AK; Grundtman C; Borg K; Alexanderson H; Andersson U; Harris HE; Lundberg IE
Arthritis Rheum; 2004 May; 50(5):1586-94. PubMed ID: 15146429
[TBL] [Abstract][Full Text] [Related]
9. Localization of the alpha-chemokine SDF-1 and its receptor CXCR4 in idiopathic inflammatory myopathies.
De Paepe B; Schröder JM; Martin JJ; Racz GZ; De Bleecker JL
Neuromuscul Disord; 2004 Apr; 14(4):265-73. PubMed ID: 15019705
[TBL] [Abstract][Full Text] [Related]
10. Restricted T cell receptor BV gene usage in the lungs and muscles of patients with idiopathic inflammatory myopathies.
Englund P; Wahlström J; Fathi M; Rasmussen E; Grunewald J; Tornling G; Lundberg IE
Arthritis Rheum; 2007 Jan; 56(1):372-83. PubMed ID: 17195241
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of interleukin-1 alpha, its type I receptor and antagonist in keratocystic odontogenic tumors.
Suyama Y; Kubota Y; Ninomiya T; Shirasuna K
J Oral Pathol Med; 2008 Oct; 37(9):560-4. PubMed ID: 18624935
[TBL] [Abstract][Full Text] [Related]
12. Distribution of glucocorticoid receptor alpha and beta subtypes in the idiopathic inflammatory myopathies.
De Bleecker JL; De Paepe B; Vervaet VL; Arys B; Creus KK; Werbrouck BF; Martin JJ
Neuromuscul Disord; 2007 Feb; 17(2):186-93. PubMed ID: 17251024
[TBL] [Abstract][Full Text] [Related]
13. Signal transducer and activator of transcription 1 in human muscle: implications in inflammatory myopathies.
Illa I; Gallardo E; Gimeno R; Serrano C; Ferrer I; Juárez C
Am J Pathol; 1997 Jul; 151(1):81-8. PubMed ID: 9212734
[TBL] [Abstract][Full Text] [Related]
14. Contribution of IL-1 to resistance to Streptococcus pneumoniae infection.
Kafka D; Ling E; Feldman G; Benharroch D; Voronov E; Givon-Lavi N; Iwakura Y; Dagan R; Apte RN; Mizrachi-Nebenzahl Y
Int Immunol; 2008 Sep; 20(9):1139-46. PubMed ID: 18596024
[TBL] [Abstract][Full Text] [Related]
15. The RAGE pathway in inflammatory myopathies and limb girdle muscular dystrophy.
Haslbeck KM; Friess U; Schleicher ED; Bierhaus A; Nawroth PP; Kirchner A; Pauli E; Neundörfer B; Heuss D
Acta Neuropathol; 2005 Sep; 110(3):247-54. PubMed ID: 15986224
[TBL] [Abstract][Full Text] [Related]
16. Alpha-chemokine receptors CXCR1-3 and their ligands in idiopathic inflammatory myopathies.
De Paepe B; De Keyzer K; Martin JJ; De Bleecker JL
Acta Neuropathol; 2005 Jun; 109(6):576-82. PubMed ID: 15937690
[TBL] [Abstract][Full Text] [Related]
17. Chemokine-like factor expression in the idiopathic inflammatory myopathies.
Chowdhury MH; Nagai A; Terashima M; Sheikh A; Murakawa Y; Kobayashi S; Yamaguchi S
Acta Neurol Scand; 2008 Aug; 118(2):106-14. PubMed ID: 18294340
[TBL] [Abstract][Full Text] [Related]
18. Platelet-endothelial cell adhesion molecule-1 and CD146: soluble levels and in situ expression of cellular adhesion molecules implicated in the cohesion of endothelial cells in idiopathic inflammatory myopathies.
Figarella-Branger D; Schleinitz N; Boutière-Albanèse B; Camoin L; Bardin N; Guis S; Pouget J; Cognet C; Pellissier JF; Dignat-George F
J Rheumatol; 2006 Aug; 33(8):1623-30. PubMed ID: 16881117
[TBL] [Abstract][Full Text] [Related]
19. Expression of the beta chemokines CCL3, CCL4, CCL5 and their receptors in idiopathic inflammatory myopathies.
Civatte M; Bartoli C; Schleinitz N; Chetaille B; Pellissier JF; Figarella-Branger D
Neuropathol Appl Neurobiol; 2005 Feb; 31(1):70-9. PubMed ID: 15634233
[TBL] [Abstract][Full Text] [Related]
20. Reduced IL-1Ra/IL-1 ratio in ultraviolet B-exposed skin of patients with polymorphic light eruption.
Janssens AS; Pavel S; Tensen CP; Teunissen MB; Out-Luiting JJ; Willemze R; de Gruijl FR
Exp Dermatol; 2009 Mar; 18(3):212-7. PubMed ID: 19046297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
